Literature DB >> 25399016

Optimal number of days for home blood pressure measurement.

Teemu J Niiranen1, Kei Asayama2, Lutgarde Thijs3, Jouni K Johansson4, Azusa Hara3, Atsushi Hozawa5, Ichiro Tsuji6, Takayoshi Ohkubo2, Antti M Jula4, Yutaka Imai7, Jan A Staessen8.   

Abstract

BACKGROUND: Current guidelines make no outcome-based recommendations on the optimal measurement schedule for home blood pressure (BP).
METHODS: We enrolled 4,802 randomly recruited participants from three populations. The participants were classified by their (i) cross-classification according to office and home BP (normotension, masked hypertension, white-coat hypertension, and sustained hypertension) and (ii) home BP level (normal BP, high normal BP, grade 1 and 2 hypertension), while the number of home measurement days was increased from 1 to 7. The prognostic accuracy of home BP with an increasing number of home BP measurement days was also assessed by multivariable-adjusted Cox models.
RESULTS: Agreement in classification between consecutive measurement days indicated near perfect agreement (κ ≥ 0.9) after the sixth measurement day for both office and home BP cross-classification (97.8% maintained classification, κ = 0.97) and home BP level (93.6% maintained classification, κ = 0.91). Over a follow-up of 8.3 years, 568 participants experienced a cardiovascular event, and the first home BP measurement alone predicted events significantly (P ≤ 0.003). The confidence intervals (CIs) were too wide and overlapping to show superiority of multiple measurement days over the first measurement day (hazard ratios per 10mm Hg increase in systolic BP at initial day, 1.11 [CI 1.07-1.16]; that at 1-7 days, 1.18 [CI 1.12-1.24]). Masked hypertension, but not white-coat hypertension, was associated with increased cardiovascular risk, irrespective of the number of home measurement days.
CONCLUSION: Even a single home BP measurement is a potent predictor of cardiovascular events, whereas seven home measurement days may be needed to reliably diagnose hypertension. © American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  blood pressure; cardiovascular diseases; home blood pressure monitoring; hypertension; meta-analysis; prognosis.

Mesh:

Year:  2014        PMID: 25399016     DOI: 10.1093/ajh/hpu216

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  17 in total

1.  Relationship between office and home blood pressure with increasing age: The International Database of HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO).

Authors:  Angeliki Ntineri; George S Stergiou; Lutgarde Thijs; Kei Asayama; José Boggia; Nadia Boubouchairopoulou; Atsushi Hozawa; Yutaka Imai; Jouni K Johansson; Antti M Jula; Anastasios Kollias; Leonella Luzardo; Teemu J Niiranen; Kyoko Nomura; Takayoshi Ohkubo; Ichiro Tsuji; Christophe Tzourio; Fang-Fei Wei; Jan A Staessen
Journal:  Hypertens Res       Date:  2016-04-07       Impact factor: 3.872

2.  Recommended standards for assessing blood pressure in human research where blood pressure or hypertension is a major focus.

Authors: 
Journal:  J Hum Hypertens       Date:  2017-04-13       Impact factor: 3.012

3.  The impact of unrecorded readings on the precision and diagnostic performance of home blood pressure monitoring: a statistical study.

Authors:  Félix Rinfret; Franck Ouattara; Lyne Cloutier; Pierre Larochelle; Monica Ilinca; Maxime Lamarre-Cliche
Journal:  J Hum Hypertens       Date:  2018-02-21       Impact factor: 3.012

4.  2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.

Authors:  Tzung-Dau Wang; Chern-En Chiang; Ting-Hsing Chao; Hao-Min Cheng; Yen-Wen Wu; Yih-Jer Wu; Yen-Hung Lin; Michael Yu-Chih Chen; Kwo-Chang Ueng; Wei-Ting Chang; Ying-Hsiang Lee; Yu-Chen Wang; Pao-Hsien Chu; Tzu-Fan Chao; Hsien-Li Kao; Charles Jia-Yin Hou; Tsung-Hsien Lin
Journal:  Acta Cardiol Sin       Date:  2022-05       Impact factor: 1.800

5.  Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension: Analysis From the Dallas Heart Study.

Authors:  Danielle Tientcheu; Colby Ayers; Sandeep R Das; Darren K McGuire; James A de Lemos; Amit Khera; Norman Kaplan; Ronald Victor; Wanpen Vongpatanasin
Journal:  J Am Coll Cardiol       Date:  2015-11-17       Impact factor: 24.094

6.  Patients' and clinicians' views on the optimum schedules for self-monitoring of blood pressure: a qualitative focus group and interview study.

Authors:  Sabrina Grant; James A Hodgkinson; Siobhan L Milner; Una Martin; Alice Tompson; Fd Richard Hobbs; Jonathan Mant; Richard J McManus; Sheila M Greenfield
Journal:  Br J Gen Pract       Date:  2016-07-05       Impact factor: 5.386

7.  Recommended standards for assessing blood pressure in human research where blood pressure or hypertension is a major focus.

Authors: 
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-12-02       Impact factor: 3.738

8.  Evaluation of the Use of Home Blood Pressure Measurement Using Mobile Phone-Assisted Technology: The iVitality Proof-of-Principle Study.

Authors:  Liselotte W Wijsman; Edo Richard; Ricardo Cachucho; Anton Jm de Craen; Susan Jongstra; Simon P Mooijaart
Journal:  JMIR Mhealth Uhealth       Date:  2016-06-13       Impact factor: 4.773

9.  Does Antihypertensive Drug Class Affect Day-to-Day Variability of Self-Measured Home Blood Pressure? The HOMED-BP Study.

Authors:  Kei Asayama; Takayoshi Ohkubo; Tomohiro Hanazawa; Daisuke Watabe; Miki Hosaka; Michihiro Satoh; Daisaku Yasui; Jan A Staessen; Yutaka Imai
Journal:  J Am Heart Assoc       Date:  2016-03-23       Impact factor: 5.501

10.  The QardioArm App in the Assessment of Blood Pressure and Heart Rate: Reliability and Validity Study.

Authors:  Victoria Mazoteras Pardo; Marta E Losa Iglesias; José López Chicharro; Ricardo Becerro de Bengoa Vallejo
Journal:  JMIR Mhealth Uhealth       Date:  2017-12-15       Impact factor: 4.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.